Related Experiment Video
Updated: Jul 27, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
[Metformin for type-2 diabetes mellitus. Systematic review and meta-analysis]
A Sáenz Calvo1, I Fernández Esteban, A Mataix Sanjuán
1Centro de Salud Pozuelo 1, Area 6, Instituto Madrileño de la Salud, Pozuelo de Alarcón, Madrid, Spain. antoniosaenz@ya.com
Atencion Primaria
|September 13, 2005
Summary
Metformin effectively reduces clinical events in type 2 diabetes mellitus compared to other treatments. This systematic review confirms metformin
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder.
- Effective management of T2DM is crucial to prevent long-term complications.
- Metformin is a widely used first-line oral anti-diabetic agent.
Purpose of the Study:
- To systematically review and evaluate the efficacy of metformin.
- To compare metformin's effects against placebo, diet, other oral anti-diabetics, and insulin in T2DM patients.
Main Methods:
- Systematic review of 29 randomized clinical trials.
- Data sourced from MEDLINE, EMBASE, LILACS, and Cochrane Library (up to 2003).
- Analysis included mortality, morbidity, and biochemical outcomes.
Main Results:
- Metformin demonstrated superior efficacy in reducing clinical events compared to sulfonylureas, insulin, and diet.
- Significant reductions observed in glycosylated hemoglobin A1, LDL cholesterol, and body weight.
- Metformin showed benefits over placebo, diet, and thiazolidinediones for glycemic control.
Conclusions:
- Long-term use of metformin is associated with reduced risks of diabetes-related clinical events.
- No long-term trials directly compared metformin with alpha-glucosidase inhibitors, meglitinides, or thiazolidinediones for primary outcomes.
- Alternative treatments did not show greater benefits for the evaluated secondary outcomes.
Related Concept Videos
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...